National Health Investors, Inc. (NHI) SEC Filings & Earnings Calls
EquiReason read 28 National Health Investors, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-27 — National Health Investors entered into a Change in Control Severance Agreement with Christian Maingot..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 3.3B
- P/E TTM
- 19.4
- Dividend yield
- 5.5%
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
27 Aug 20268-K · 5.02National Health Investors entered into a Change in Control Severance Agreement with Christian Maingot.open
Risks flagged
Potential change in control risk; severance terms disclosed.
“CIC Severance Agreement with 2x salary and bonus, non-compete, etc.”
10 Aug 20268-K · 2.02Net income attributable to common stockholders per diluted share $1.15 (+46% y/y); NAREIT FFO per diluted share $1.19 (+0% y/y); Normalized FFO per diluted share $1.19 (-2% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net income attributable to common stockholders per diluted share · Q2-2026 | $1.15 | +46% y/y |
| NAREIT FFO per diluted share · Q2-2026 | $1.19 | 0% y/y |
| Normalized FFO per diluted share · Q2-2026 | $1.19 | -3% y/y |
| Normalized FAD · Q2-2026 | $62M | +10% y/y |
| SHOP invested capital · SHOP · Q2-2026 | $855M | +137% y/y |
Risks flagged
CFO transition costs and higher G&A expenses may pressure near-term profitability.
“General and administrative expenses increased $2.7 million, or 44.0%, primarily due to higher compensation costs and costs incurred in the current period related to the Company’s CFO transition.” · word for word
10 Aug 202610-QNHI reported strong 2025 results with Normalized FFO per share up 10.6% and SHOP NOI up 57%, exceeding initial guidance.earningsopen
Figures in the filing · each found in the filing text
| Normalized FFO per share · FY2025 | $4.91 | +11% y/y |
| Normalized Funds Available for Distribution · FY2025 | $232M | +14% y/y |
| Nareit FFO per share · FY2025 | $4.65 | +2% y/y |
| SHOP NOI · SHOP · FY2025 | $19M | +57% y/y |
| SHOP Same Store NOI · SHOP · FY2025 | $13M | +8% y/y |
| Net Debt to Adjusted EBITDA · FY2025 | $3.80 | |
| Total Shareholder Return · FY2025 | 15.7% | |
| Investment Activity · FY2025 | $392M |
Guidance
2025 NFFO per share and FAD performance exceeded the midpoints of initial annual guidance by approximately 6% and 5%, respectively
NHI exceeded initial 2025 guidance on NFFO per share and FAD, with strong investment activity and balance sheet improvement.
Risks flagged
Tenant concentration risk
“Senior Living and Bickford are significant tenants; Bickford has been a cash basis tenant since 2022 with going concern doubts.”
Bickford credit risk
“Bickford has been a cash basis tenant since 2022 when we received financial information from Bickford raising substantial doubt about its ability to continue as a going concern. As of June 30, 2026, these concerns had not been alleviated.” · word for word
NHC lease default and disposition
“We provided formal written notice to NHC that it is in default of the triple-net master lease as a result of NHC’s failure to remedy its non-compliance with certain non-monetary provisions.”
1 Jul 20268-K · 1.02, 2.01Terminated a material definitive agreement, ending a significant contract; completed an acquisition or disposition of significant assetsopen
Risks flagged
Loss of rental income from 35 facilities may reduce recurring revenue.
“Master Lease was terminated with respect to all of the Facilities other than the four skilled nursing facilities located in Florida.”
4 May 20268-K · 7.01NHI filed supplemental information for Q1 2026, providing portfolio and financial updates. No explicit guidance or material event beyond routine quarterly disclosure.earningsopen
Figures in the filing · each found in the filing text
| Adjusted NOI · total · Q1-2026 | $322M |
Risks flagged
Generic forward-looking risk factors; no new specific risks identified.
“Standard risk language including tariffs, pandemics, and activist investors.”
4 May 20268-K · 2.02NHI reported Q1 2026 earnings with NAREIT FFO per share up 7.9% YoY to $1.23, Normalized FFO up 7.0% to $1.23, and Normalized FAD up 11.6% to $62.5M. However, full-year guidance was cut: NAREIT FFO lowered to $4.74-$4.79 from $4.94-$4.99, aearningsopen
Figures in the filing · each found in the filing text
| NAREIT FFO per diluted share · Q1-2026 | $1.23 | +8% y/y |
| Normalized FFO per diluted share · Q1-2026 | $1.23 | +7% y/y |
| Normalized FAD · Q1-2026 | $63M | +12% y/y |
| Net income per diluted share · Q1-2026 | $0.82 | +11% y/y |
| Same-store resident fees less senior housing operating expenses change · SHOP · Q1-2026 | -2.4% | |
| Invested capital in SHOP · SHOP · Q1-2026 | $743M | +106% y/y |
Guidance
FY2026 NAREIT FFO per diluted share lowered to $4.74-$4.79 from $4.94-$4.99; Normalized FFO per diluted share lowered to $4.74-$4.79 from $4.94-$4.99; Normalized FAD lowered to $240.6-$243.7M from $248.9-$251.4M
Guidance cut for FY2026 across all key metrics, indicating weaker outlook despite strong Q1 results. Management remains positive on long-term strategy.
Risks flagged
Same-store SHOP occupancy decline indicates near-term operating headwinds in senior housing portfolio.
“On a same store basis, resident fees and services, less senior housing operating expenses, declined 2.4% primarily due to a decline in occupancy.”
Guidance cut for FY2026 NAREIT FFO and Normalized FAD signals weaker outlook despite strong Q1.
“NHI is updating its 2026 full year guidance range as follows: NAREIT FFO per diluted share from a range of $4.94 - $4.99 to a range of $4.74 - $4.79; Normalized FAD from a range of $248.9 million - $251.4 million to a range of $240.6 million - $243.7 million.”
NHC portfolio sale execution risk and HSR waiting period could delay closing.
“The Company anticipates closing the transaction on July 1, 2026, subject to certain customary closing conditions, including the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.” · word for word
4 May 202610-QTotal NOI $84M (+11% y/y); Real Estate Investments NOI $75M; SHOP NOI $9M (+0% y/y)open
Figures in the filing · each found in the filing text
| Total NOI · Total · Q1-2026 | $84M | +11% y/y |
| Real Estate Investments NOI · Real Estate Investments · Q1-2026 | $75M | |
| SHOP NOI · SHOP · Q1-2026 | $9M | 0% y/y |
| Revenue · Total · Q1-2026 | $115M | +29% y/y |
| Net Income · Total · Q1-2026 | $40M | +18% y/y |
| Operating Cash Flow · Total · Q1-2026 | $53M | +15% y/y |
Risks flagged
Tenant Concentration Risk
“Senior Living, Bickford, and NHC together represent 32.1% of total revenues as of Q1 2026.”
Bickford Credit Risk
“Bickford continues to be recognized as a cash basis tenant until substantial doubt about its ability to continue as a going concern has been alleviated.”
Interest Rate Risk
“Interest expense increased 4.9% year-over-year due to new senior notes issuance.”
21 Apr 20268-K · 1.01, 1.02, 7.01NHI announced sale of 35 skilled nursing and independent living facilities to NHC for $560M, reducing SNF exposure and increasing private-pay senior housing concentration.being acquiredopen
Risks flagged
Transaction may not close, potentially impacting stock price and operations.
“Forward-looking statements highlight risks of non-completion and adverse effects on stock price.”
3 Apr 2026DEF 14ANHI reported strong 2025 results with Normalized FFO per share up 10.6% and SHOP NOI up 57%, exceeding initial guidance.earningsopen
Figures in the filing · each found in the filing text
| Normalized FFO per share · FY2025 | $4.91 | +11% y/y |
| Normalized Funds Available for Distribution · FY2025 | $232M | +14% y/y |
| Nareit FFO per share · FY2025 | $4.65 | +2% y/y |
| SHOP NOI · SHOP · FY2025 | $19M | +57% y/y |
| SHOP Same Store NOI · SHOP · FY2025 | $13M | +8% y/y |
| Net Debt to Adjusted EBITDA · FY2025 | $3.80 | |
| Total Shareholder Return · FY2025 | 15.7% | |
| Investment Activity · FY2025 | $392M |
Guidance
2025 NFFO per share and FAD performance exceeded the midpoints of initial annual guidance by approximately 6% and 5%, respectively
NHI exceeded initial 2025 guidance on NFFO per share and FAD, with strong investment activity and balance sheet improvement.
Risks flagged
Tenant concentration risk
“Senior Living and Bickford are significant tenants; Bickford has been a cash basis tenant since 2022 with going concern doubts.”
Bickford credit risk
“Bickford has been a cash basis tenant since 2022 when we received financial information from Bickford raising substantial doubt about its ability to continue as a going concern. As of June 30, 2026, these concerns had not been alleviated.”
NHC lease default and disposition
“We provided formal written notice to NHC that it is in default of the triple-net master lease as a result of NHC’s failure to remedy its non-compliance with certain non-monetary provisions.” · word for word
16 Mar 20268-K · 8.01National Health Investors entered into an equity distribution agreement for an at-the-market offering of common stock.open
Risks flagged
Potential dilution from future ATM issuances.
“Equity Distribution Agreement allows for sale of common stock from time to time.”
26 Feb 20268-K · 7.01SHOP NOI $7M (+125% y/y); SHOP occupancy 86.9; SHOP RevPOR $3,918.00open
Figures in the filing · each found in the filing text
| SHOP NOI · SHOP · Q4-2025 | $7M | +125% y/y |
| SHOP occupancy · SHOP · Q4-2025 | 86.9% | |
| SHOP RevPOR · SHOP · Q4-2025 | $3918.00 | |
| SHOP NOI margin · SHOP · Q4-2025 | 23.8% | |
| Net Debt to Adjusted EBITDA · Q4-2025 | $3.80 | |
| Total liquidity · Q4-2025 | $900M |
26 Feb 20268-K · 2.02Net income attributable to common stockholders per diluted share $0.80 (-16% y/y); NAREIT FFO per diluted share $1.22 (-2% y/y); Normalized FFO per diluted share $1.22 (+9% y/y); Guidance: 2026 Normalized FFO guidance $4.94-$4.99 vs 2025 acearningsopen
Figures in the filing · each found in the filing text
| Net income attributable to common stockholders per diluted share · Q4-2025 | $0.80 | -16% y/y |
| NAREIT FFO per diluted share · Q4-2025 | $1.22 | -2% y/y |
| Normalized FFO per diluted share · Q4-2025 | $1.22 | +9% y/y |
| Normalized FAD · Q4-2025 | $58M | +11% y/y |
| Net income attributable to common stockholders per diluted share (FY) · FY2025 | $3.02 | -4% y/y |
| NAREIT FFO per diluted share (FY) · FY2025 | $4.65 | +2% y/y |
| Normalized FFO per diluted share (FY) · FY2025 | $4.91 | +11% y/y |
| Normalized FAD (FY) · FY2025 | $232M | +14% y/y |
| Rental income · Real Estate Investments · Q4-2025 | $5M | +7% y/y |
| Resident fees and services, less senior housing operating expenses · SHOP · Q4-2025 | $4M | +125% y/y |
Guidance
2026 Normalized FFO guidance $4.94-$4.99 vs 2025 actual $4.91; Normalized FAD $248.9M-$251.4M vs 2025 $232.1M
2026 guidance raised across all metrics; management confident in SHOP growth and investment pipeline
Risks flagged
Same-store SHOP occupancy decline and NOI pressure
“Same Store SHOP NOI declined 0.9% due to occupancy decline; sequential margin pressure”
G&A expense growth outpacing revenue growth
“General and administrative expenses increased 40.4% due to higher compensation and professional fees”
Proxy contest and transaction costs impacting net income
“$1.6M proxy contest expenses and $1.2M transaction costs in FY2025”
26 Feb 202610-KTotal Revenues $376M (+12% y/y); Net Income $74M (-34% y/y); Net Operating Income (NOI) - Total Portfolio $304Mopen
Figures in the filing · each found in the filing text
| Total Revenues · FY2025 | $376M | +12% y/y |
| Net Income · FY2025 | $74M | -34% y/y |
| Net Operating Income (NOI) - Total Portfolio · FY2025 | $304M | |
| NOI - Real Estate Investments Segment · Real Estate Investments · FY2025 | $285M | |
| NOI - SHOP Segment · SHOP · FY2025 | $19M | |
| Portfolio Coverage Ratio (TTM) · Q3-2025 | $2.19 | +5% y/y |
| SHOP Segment Occupancy · SHOP · Q4-2025 | 86.9% |
Risks flagged
Tenant Concentration Risk - NHC Default
“On September 8, 2025, we provided formal written notice to NHC that it is in default of the triple-net master lease” · word for word
Interest Rate Exposure
“Certain of our debt obligations are floating rate obligations with interest rates that vary with the movement of the SOFR or other indexes.” · word for word
Bickford Credit Risk
“Bickford was on cash basis accounting; $1.3M mezzanine loan fully reserved.”
6 Nov 20258-K · 2.02Net income attributable to common stockholders per diluted share $0.69 (+6% y/y); NAREIT FFO per diluted share $1.09 (+6% y/y); Normalized FFO per diluted share $1.32 (+28% y/y); Guidance: FY2025 Normalized FFO guidance raised to $4.88-$4.9earningsopen
Figures in the filing · each found in the filing text
| Net income attributable to common stockholders per diluted share · Q3-2025 | $0.69 | +6% y/y |
| NAREIT FFO per diluted share · Q3-2025 | $1.09 | +6% y/y |
| Normalized FFO per diluted share · Q3-2025 | $1.32 | +28% y/y |
| Normalized FAD · Q3-2025 | $62M | +26% y/y |
| Net income attributable to common stockholders per diluted share (9M) · 9M-2025 | $2.22 | +2% y/y |
| NAREIT FFO per diluted share (9M) · 9M-2025 | $3.42 | +3% y/y |
| Normalized FFO per diluted share (9M) · 9M-2025 | $3.69 | +11% y/y |
| Normalized FAD (9M) · 9M-2025 | $174M | +15% y/y |
| Rental income change · Real Estate Investments · Q3-2025 | $-1M | -2% y/y |
| SHOP NOI · SHOP · Q3-2025 | $2M | +63% y/y |
Guidance
FY2025 Normalized FFO guidance raised to $4.88-$4.91 from $4.78-$4.82; Normalized FAD to $231.7M-$233.5M from $227.9M-$229.8M
FY2025 guidance raised for third time; management confident in SHOP growth and investment pipeline
Risks flagged
Same-store SHOP occupancy decline and NOI pressure
“Same Store SHOP NOI declined 2.2% due to occupancy decline; sequential margin pressure”
G&A expense growth outpacing revenue growth
“General and administrative costs increased 31.2% due to higher incentive compensation and professional fees”
Proxy contest and transaction costs impacting net income
“$1.6M proxy contest expenses and $1.2M transaction costs in 9M 2025”
6 Nov 202510-QNHI reported Q3 2025 results with total revenue +8.3% YoY and net income +15.1% YoY, driven by acquisitions and SHOP expansion, but offset by tenant credit issues and lease transitions.earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q3-2025 | $90M | +8% y/y |
| Net income attributable to common stockholders · Q3-2025 | $33M | +15% y/y |
| Net cash provided by operating activities · 9M-2025 | $169M | +12% y/y |
| Total NOI · 9M-2025 | $224M | +7% y/y |
| Real Estate Investments NOI · Real Estate Investments · 9M-2025 | $193M | |
| SHOP NOI · SHOP · 9M-2025 | $12M | |
| Total revenues (9M) · 9M-2025 | $270M | +8% y/y |
| Net income attributable to common stockholders (9M) · 9M-2025 | $104M | +10% y/y |
Risks flagged
Tenant credit concentration and default risk
“We had two tenants, including Bickford, on the cash basis of accounting for revenue recognition... On September 8, 2025, we provided formal written notice to NHC that it is in default of the triple-net master lease.” · word for word
Lease transition execution risk
“The concurrent transactions executed on August 1, 2025, which resulted in the transfer of seven properties from the Real Estate Investments segment to the SHOP segment... We recognized an aggregate $6.9 million reduction in rental income, which included $12.1 million in write offs related to straight-line rents receivable.” · word for word
Regulatory and reimbursement risk for medical facilities
“Medical facilities within our Real Estate Investments segment receive payment for services primarily from Medicare, Medicaid and health insurance... Medical facilities are subject to federal and state regulatory oversight.” · word for word
National Health Investors, Inc. — questions
- What did National Health Investors, Inc. file recently?
- 28 SEC filings in the last 12 months. Latest: 8-K on 2026-08-27 — National Health Investors entered into a Change in Control Severance Agreement with Christian Maingot.
Every figure on this page comes from National Health Investors, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.